Clinical Trial Update: Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer [NA]

View source ↗

Summary

A recruiting clinical trial is studying moderately hypofractionated adaptive postoperative radiotherapy for high-risk endometrial cancer. The sponsor listed is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Xiaorong Hou | Conditions: Endometrial Cancer, Hypofractionated Dose | NA | Status: RECRUITING